Hi everybody, and welcome back to our series of frequently asked questions. I’m Jim Adler, the tough, smart lawyer. And today’s topic is on the prescription drug Elmiron and its link to retinal damage and sadly, blindness.
Elmiron is a prescription drug used to treat IC, an uncommon bladder condition that can cause discomfort and pain in the pelvic region. It is also known as interstitial cystitis. Elmiron was approved by the FDA in 1996 and it has been estimated that hundreds of thousands of people, mostly women, have used the drug since then.
In July of 2019, the Review of Ophthalmology published an article that identified a clear link between Elmiron and a “preventable, vision-threatening medication toxicity” that could result in serious eye and vision impairment or blindness.
Some of the most common symptoms of Elmiron include blurred vision while reading, difficulty driving at night, trouble adjusting to dim lighting and glare, blind spots, distorted vision, or in general any loss of vision.
Lawsuits are pending due to failure by the manufacturer to warn about these potential side effects on the product label. In June of 2020 the manufacturer added a warning to the product labeling to inform users. Unfortunately, that did not help those who had been using the drug for years and had already developed serious eye and vision damage or blindness.
If you or a loved have used the drug Elmiron and have experienced vision damage or blindness, you may be entitled to compensation and benefits. You should talk to a personal injury lawyer as soon as possible to ensure that your legal rights are protected.
If you have questions about this information or would like to discuss your case, you can get in touch with Jim Adler & Associates by way of the contact form at jimadler.com or by giving us a call at 1-800-567-7575.